{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:36:24Z","timestamp":1794612984168,"version":"4.9.1"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.critrevonc.2025.104743","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:03:46Z","timestamp":1745413426000},"page":"104743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Extracellular vesicles in acute myeloid leukemia: The role in disease pathogenesis, potential biomarker, and application in clinical settings"],"prefix":"10.1016","volume":"211","author":[{"given":"Madhura","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-7967","authenticated-orcid":false,"given":"Umesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2025.104743_bib1","article-title":"Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century","volume":"44","author":"Hemminki","year":"2024","journal-title":"Blood Cancer J. 14"},{"key":"10.1016\/j.critrevonc.2025.104743_bib2","article-title":"A survival analysis of acute myeloid leukemia patients treated with intensive chemotherapy: a single center experience","volume":"15","author":"Jimbu","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.critrevonc.2025.104743_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106727","article-title":"A concise review on the molecular genetics of acute myeloid leukemia","volume":"111","author":"Padmakumar","year":"2021","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2025.104743_bib4","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.2019003262","article-title":"Epigenetic therapies in acute myeloid leukemia: where to from here?","volume":"134","author":"Fennell","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib5","article-title":"The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017","volume":"72","author":"Yi","year":"2020","journal-title":"J. Hematol. Oncol. 13"},{"key":"10.1016\/j.critrevonc.2025.104743_bib6","unstructured":"Vakiti, A., Reynolds, S.B. & Mewawalla, P. in StatPearls (StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC., 2024)."},{"key":"10.1016\/j.critrevonc.2025.104743_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.critrevonc.2025.104743_bib8","article-title":"Global, national, and regional burden of acute myeloid leukemia among 60-89\u2009years-old individuals: insights from a study covering the period 1990 to 2019","volume":"11","author":"Chen","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.critrevonc.2025.104743_bib9","first-page":"73","article-title":"Acute myeloid leukemia","volume":"2002","author":"Giles","year":"2002","journal-title":"ASH Educ. Program Book"},{"key":"10.1016\/j.critrevonc.2025.104743_bib10","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s12015-021-10308-6","article-title":"Acute Myeloid Leukemia Stem Cells: Origin, Characteristics, and Clinical Implications","volume":"18","author":"Long","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.critrevonc.2025.104743_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med"},{"key":"10.1016\/j.critrevonc.2025.104743_bib13","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s13346-022-01189-4","article-title":"Modelling acute myeloid leukemia (AML): What\u2019s new? A transition from the classical to the modern","volume":"13","author":"Dozzo","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.critrevonc.2025.104743_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.V61.3.456.456","article-title":"The expression of myeloid-specific antigens on myeloid leukemia cells: correlations with leukemia subclasses and implications for normal myeloid differentiation","volume":"61","author":"Ball","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ajh.25512","article-title":"Platelet function tests predict bleeding in patients with acute myeloid leukemia and thrombocytopenia","volume":"94","author":"Just Vinholt","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib16","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1182\/blood.V90.8.2969","article-title":"Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy","volume":"90","author":"Estey","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/hematology.2020000098","article-title":"Updates in infection risk and management in acute leukemia","volume":"2020","author":"Logan","year":"2020","journal-title":"Hematology"},{"key":"10.1016\/j.critrevonc.2025.104743_bib18","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/sj.onc.1207947","article-title":"Self-renewal and solid tumor stem cells","volume":"23","author":"Al-Hajj","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104743_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","article-title":"Modern therapy of acute lymphoblastic leukemia","volume":"29","author":"Bassan","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.beha.2017.10.001","article-title":"How can one optimize induction therapy in AML?","volume":"30","author":"Luger","year":"2017","journal-title":"Best. Pr. Res Clin. Haematol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jmoldx.2018.03.005","article-title":"Molecular Minimal Residual Disease Monitoring in Acute Myeloid Leukemia: Challenges and Future Directions","volume":"20","author":"Selim","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2025.104743_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.canep.2010.04.003","article-title":"Acute myeloid leukemia incidence following radiation therapy for localized or locally advanced prostate adenocarcinoma","volume":"34","author":"Ojha","year":"2010","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib23","first-page":"1","article-title":"Efficacy of bone marrow transplantation in treating acute myeloid leukemia: a systematic review and meta-analysis","volume":"15","author":"Li","year":"2023","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.critrevonc.2025.104743_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020641","article-title":"Targeted Therapy Development in Acute Myeloid Leukemia","volume":"11","author":"Totiger","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2025.104743_bib25","first-page":"44","article-title":"A review of arsenic trioxide and acute promyelocytic leukemia","volume":"8","author":"Alimoghaddam","year":"2014","journal-title":"Int J. Hematol. Oncol. Stem Cell Res"},{"key":"10.1016\/j.critrevonc.2025.104743_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121915","article-title":"Retinoic acid receptors in acute myeloid leukemia therapy","volume":"11","author":"Martino","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104743_bib27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5045\/br.2020.S001","article-title":"Classification of acute myeloid leukemia","volume":"55","author":"Hwang","year":"2020","journal-title":"Blood Res"},{"key":"10.1016\/j.critrevonc.2025.104743_bib28","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2025.104743_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.critrevonc.2025.104743_bib31","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib32","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111263","article-title":"MicroRNAs in extracellular vesicles: A potential role in cancer progression","volume":"121","author":"Parashar","year":"2024","journal-title":"Cell Signal"},{"key":"10.1016\/j.critrevonc.2025.104743_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/blood.2021012358","article-title":"Factor VIIa suppresses inflammation and barrier disruption through the release of EEVs and transfer of microRNA 10a","volume":"139","author":"Das","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib35","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.1074\/jbc.RA119.008619","article-title":"Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition","volume":"294","author":"Das","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2025.104743_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41576-020-00292-x","article-title":"Deciphering cell-cell interactions and communication from gene expression","volume":"22","author":"Armingol","year":"2021","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.critrevonc.2025.104743_bib37","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1073\/pnas.1602171113","article-title":"Intercellular signaling through secreted proteins induces free-energy gradient-directed cell movement","volume":"113","author":"Kravchenko-Balasha","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2025.104743_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101302","article-title":"Extracellular vesicles transport RNA between cells: Unraveling their dual role in diagnostics and therapeutics","volume":"99","author":"Payandeh","year":"2024","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.critrevonc.2025.104743_bib39","doi-asserted-by":"crossref","first-page":"E1433","DOI":"10.1073\/pnas.1418401112","article-title":"Differential fates of biomolecules delivered to target cells via extracellular vesicles","volume":"112","author":"Kanada","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2025.104743_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40659-022-00405-2","article-title":"Extracellular signals regulate the biogenesis of extracellular vesicles","volume":"55","author":"Jin","year":"2022","journal-title":"Biol. Res."},{"key":"10.1016\/j.critrevonc.2025.104743_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2025.104743_bib42","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1111\/jth.15768","article-title":"Factor VIIa treatment increases circulating extracellular vesicles in hemophilia patients: Implications for the therapeutic hemostatic effect of FVIIa","volume":"20","author":"Das","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2025.104743_bib43","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood.2020008417","article-title":"Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect","volume":"137","author":"Das","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib44","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1038\/s41598-022-08561-x","article-title":"Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy","volume":"12","author":"Larson","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104743_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2024.07.022","article-title":"Coagulation protease-induced extracellular vesicles: their potential effects on coagulation and inflammation","author":"Das","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2025.104743_bib46","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.2023023518","article-title":"A potential mechanism for the cytoprotective effects of activated protein C-released endothelial extracellular vesicles","volume":"143","author":"Das","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib47","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4103\/1673-5374.324840","article-title":"Significance of intercellular communication for neurodegenerative diseases","volume":"17","author":"Cihankaya","year":"2022","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.critrevonc.2025.104743_bib48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jtha.2023.10.021","article-title":"MicroRNA-10a enrichment in factor VIIa-released endothelial extracellular vesicles: potential mechanisms","volume":"22","author":"Das","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2025.104743_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cells12151963","article-title":"Beyond Macromolecules: Extracellular Vesicles as Regulators of Inflammatory Diseases","volume":"12","author":"Das","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2025.104743_bib50","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/j.jtha.2023.08.025","article-title":"Factor VIIa releases phosphatidylserine-enriched extracellular vesicles from endothelial cells by activating acid sphingomyelinase","volume":"21","author":"Das","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2025.104743_bib51","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tcb.2020.05.003","article-title":"Classical and Nonclassical Intercellular Communication in Senescence and Ageing","volume":"30","author":"Fafi\u00e1n-Labora","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib52","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1038\/s41598-018-25725-w","article-title":"The Protease Activated Receptor2 Promotes Rab5a Mediated Generation of Pro-metastatic Microvesicles","volume":"8","author":"Das","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104743_bib53","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/mc.22891","article-title":"Protease-activated receptor 2 promotes actomyosin dependent transforming microvesicles generation from human breast cancer","volume":"57","author":"Das","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2025.104743_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194879","article-title":"Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential","volume":"15","author":"Das","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104743_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/biom13060897","article-title":"The role of extracellular vesicles in the pathogenesis of hematological malignancies: interaction with tumor microenvironment; a potential biomarker and targeted therapy","volume":"13","author":"Das","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2025.104743_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1152\/physiol.00029.2004","article-title":"Membrane Microparticles: Two Sides of the Coin","volume":"20","author":"Hugel","year":"2005","journal-title":"Physiology"},{"key":"10.1016\/j.critrevonc.2025.104743_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2025.104743_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0362-8","article-title":"Apoptotic cell-derived exosomes: messages from dying cells","volume":"52","author":"Kakarla","year":"2020","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.critrevonc.2025.104743_bib59","article-title":"Routes and mechanisms of extracellular vesicle uptake","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J. Extra Vesicles"},{"key":"10.1016\/j.critrevonc.2025.104743_bib60","article-title":"Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo","volume":"39","author":"O'Brien","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2025.104743_bib61","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2011-02-338004","article-title":"Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes","volume":"119","author":"Montecalvo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib62","doi-asserted-by":"crossref","first-page":"34211","DOI":"10.1074\/jbc.M109.041152","article-title":"Microenvironmental pH is a key factor for exosome traffic in tumor cells","volume":"284","author":"Parolini","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2025.104743_bib63","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extra Vesicles"},{"key":"10.1016\/j.critrevonc.2025.104743_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/10428194.2018.1459606","article-title":"Extracellular vesicles in hematological malignancies","volume":"60","author":"Litwi\u0144ska","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2025.104743_bib65","first-page":"1","article-title":"High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia","volume":"27","author":"Fang","year":"2020","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.critrevonc.2025.104743_bib66","first-page":"5611","article-title":"MicroRNA-10a\/b are regulators of myeloid differentiation and acute myeloid leukemia","volume":"15","author":"Bi","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2025.104743_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s13287-019-1475-7","article-title":"Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway","volume":"10","author":"Zhao","year":"2019","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.critrevonc.2025.104743_bib68","doi-asserted-by":"crossref","first-page":"ra88","DOI":"10.1126\/scisignal.aaf2797","article-title":"AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB","volume":"9","author":"Hornick","year":"2016","journal-title":"Sci. Signal"},{"key":"10.1016\/j.critrevonc.2025.104743_bib69","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41417-021-00378-6","article-title":"Acute myeloid leukemia cell-derived extracellular vesicles carrying microRNA-548ac regulate hematopoietic function via the TRIM28\/STAT3 pathway","volume":"29","author":"Zhao","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.critrevonc.2025.104743_bib70","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.18632\/aging.202893","article-title":"microRNA-1246-containing extracellular vesicles from acute myeloid leukemia cells promote the survival of leukemia stem cells via the LRIG1-meditated STAT3 pathway","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2025.104743_bib71","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.3324\/haematol.2023.284145","article-title":"Small extracellular vesicles derived from acute myeloid leukemia cells promote leukemogenesis by transferring miR-221-3p","volume":"109","author":"Li","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2025.104743_bib72","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1158\/0008-5472.CAN-12-2184","article-title":"RNA trafficking by acute myelogenous leukemia exosomes","volume":"73","author":"Huan","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104743_bib73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2017.259","article-title":"Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion","volume":"32","author":"Kumar","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2025.104743_bib74","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/leu.2015.163","article-title":"Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes","volume":"29","author":"Huan","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2025.104743_bib75","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1074\/mcp.M115.052944","article-title":"Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis","volume":"15","author":"Wojtuszkiewicz","year":"2016","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.critrevonc.2025.104743_bib76","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s13577-021-00501-7","article-title":"Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion","volume":"34","author":"Ji","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.critrevonc.2025.104743_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.766371","article-title":"Extracellular Vesicles in Acute Leukemia: A Mesmerizing Journey With a Focus on Transferred microRNAs","volume":"9","author":"Izadirad","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib78","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hon.2874","article-title":"Circ_0009910 shuttled by exosomes regulates proliferation, cell cycle and apoptosis of acute myeloid leukemia cells by regulating miR-5195-3p\/GRB10 axis","volume":"39","author":"Wang","year":"2021","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib79","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/CAD.0000000000001068","article-title":"Exosomal circ_0004136 enhances the progression of pediatric acute myeloid leukemia depending on the regulation of miR-570-3p\/TSPAN3 axis","volume":"32","author":"Bi","year":"2021","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.critrevonc.2025.104743_bib80","article-title":"Analysis of microRNA expression profiles in exosomes derived from acute myeloid leukemia by p62 knockdown and effect on angiogenesis","volume":"10","author":"Li","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.critrevonc.2025.104743_bib81","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1002\/jcp.27735","article-title":"Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis-mediated vascular remodeling","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10456-015-9486-1","article-title":"PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells","volume":"19","author":"Fang","year":"2016","journal-title":"Angiogenesis"},{"key":"10.1016\/j.critrevonc.2025.104743_bib83","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1074\/mcp.M900381-MCP200","article-title":"Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes","volume":"9","author":"Park","year":"2010","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.critrevonc.2025.104743_bib84","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/bjh.13551","article-title":"Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance","volume":"172","author":"Viola","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib85","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.leukres.2017.09.014","article-title":"Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo","volume":"62","author":"Bouvy","year":"2017","journal-title":"Leuk. Res"},{"key":"10.1016\/j.critrevonc.2025.104743_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146920","article-title":"Tumor Derived Extracellular Vesicles Modulate Gene Expression in T cells","volume":"850","author":"Pando","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.critrevonc.2025.104743_bib87","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s12026-016-8848-0","article-title":"Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis","volume":"64","author":"Venton","year":"2016","journal-title":"Immunol. Res"},{"key":"10.1016\/j.critrevonc.2025.104743_bib88","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.vaccine.2019.01.079","article-title":"Exosomes in the serum of Acute Myeloid Leukemia patients induce dendritic cell tolerance: Implications for immunotherapy","volume":"37","author":"Benites","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.critrevonc.2025.104743_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1477610","article-title":"The role of extracellular vesicles in the pathogenesis of gynecological cancer","volume":"14","author":"Chatterjee","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib90","doi-asserted-by":"crossref","first-page":"71477","DOI":"10.18632\/oncotarget.12216","article-title":"The human nucleophosmin 1 mutation A inhibits myeloid differentiation of leukemia cells by modulating miR-10b","volume":"7","author":"Zou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104743_bib91","doi-asserted-by":"crossref","first-page":"21558","DOI":"10.1073\/pnas.1016611107","article-title":"MicroRNA miR-125b causes leukemia","volume":"107","author":"Bousquet","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2025.104743_bib92","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1476-4598-10-108","article-title":"Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104743_bib93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000491584","article-title":"Elevated Serum Exosomal miR-125b Level as a Potential Marker for Poor Prognosis in Intermediate-Risk Acute Myeloid Leukemia","volume":"140","author":"Jiang","year":"2018","journal-title":"Acta Haematol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib94","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1039\/D2NA00959E","article-title":"The potential role of serum extracellular vesicle derived small RNAs in AML research as non-invasive biomarker","volume":"5","author":"Li","year":"2023","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.critrevonc.2025.104743_bib95","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3324\/haematol.2010.039743","article-title":"Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1","volume":"96","author":"Szczepanski","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2025.104743_bib96","doi-asserted-by":"crossref","first-page":"10569","DOI":"10.1021\/acs.analchem.0c01464","article-title":"Simultaneous Detection of a Cluster of Differentiation Markers on Leukemia-Derived Exosomes by Multiplex Immuno-Polymerase Chain Reaction via Capillary Electrophoresis Analysis","volume":"92","author":"Singh","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.critrevonc.2025.104743_bib97","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2014.00160","article-title":"Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia","volume":"5","author":"Hong","year":"2014","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104743_bib98","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1158\/1078-0432.CCR-09-1961","article-title":"Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee","volume":"16","author":"Ivy","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104743_bib99","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/sim.4357","article-title":"Optimal sample sizes for phase II clinical trials and pilot studies","volume":"31","author":"Stallard","year":"2012","journal-title":"Stat. Med"},{"key":"10.1016\/j.critrevonc.2025.104743_bib100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood-2002-09-2937","article-title":"New designs for phase 2 clinical trials","volume":"102","author":"Estey","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104743_bib101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/0253-7613.68417","article-title":"Adaptive design clinical trials: Methodology, challenges and prospect","volume":"42","author":"Mahajan","year":"2010","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.critrevonc.2025.104743_bib102","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2174\/156652309789753392","article-title":"Uncertainty in the translation of preclinical experiments to clinical trials. Why do most phase III clinical trials fail?","volume":"9","author":"Lowenstein","year":"2009","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.critrevonc.2025.104743_bib103","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010643","article-title":"Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry","volume":"6","author":"Zhang","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.critrevonc.2025.104743_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009951","article-title":"MicroRNAs are minor constituents of extracellular vesicles that are rarely delivered to target cells","volume":"17","author":"Albanese","year":"2021","journal-title":"PLoS Genet"},{"key":"10.1016\/j.critrevonc.2025.104743_bib105","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extra Vesicles"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T16:29:18Z","timestamp":1749486558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825001313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":105,"alternative-id":["S1040842825001313"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104743","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles in acute myeloid leukemia: The role in disease pathogenesis, potential biomarker, and application in clinical settings","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104743"}}